Related Experiment Video
Updated: May 29, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon
Eleni Makrodouli1, Eftychia Oikonomou, Michal Koc
1Laboratory of Signal Mediated Gene Expression, Institute of Biological Research and Biotechnology, National Hellenic Research Foundation, Vas, Constantinou Ave. 48, 11635, Athens, Greece.
Background:
Colorectal cancer is a common disease that involves genetic alterations, such as inactivation of tumour suppressor genes and activation of oncogenes. Among them are RAS and BRAF mutations, which rarely coexist in the same tumour. Individual members of the Rho (Ras homology) GTPases contribute with distinct roles in tumour cell morphology, invasion and metastasis. The aim of this study is to dissect cell migration and invasion pathways that are utilised by BRAFV600E as compared to KRASG12V and HRASG12V oncoproteins. In particular, the role of RhoA (Ras homolog gene family, member A), Rac1 (Ras-related C3 botulinum toxin substrate 1) and Cdc42 (cell division cycle 42) in cancer progression induced by each of the three oncogenes is described.
Methods:
Colon adenocarcinoma cells with endogenous as well as ectopically expressed or silenced oncogenic mutations of BRAFV600E, KRASG12V and HRASG12V were employed. Signalling pathways and Rho GTPases were inhibited with specific kinase inhibitors and siRNAs. Cell motility and invasion properties were correlated with cytoskeletal properties and Rho GTPase activities.
Results:
Evidence presented here indicate that BRAFV600E significantly induces cell migration and invasion properties in vitro in colon cancer cells, at least in part through activation of RhoA GTPase. The relationship established between BRAFV600E and RhoA activation is mediated by the MEK-ERK pathway. In parallel, KRASG12V enhances the ability of colon adenocarcinoma cells Caco-2 to migrate and invade through filopodia formation and PI3K-dependent Cdc42 activation. Ultimately increased cell migration and invasion, mediated by Rac1, along with the mesenchymal morphology obtained through the Epithelial-Mesenchymal Transition (EMT) were the main characteristics rendered by HRASG12V in Caco-2 cells. Moreover, BRAF and KRAS oncogenes are shown to cooperate with the TGFβ-1 pathway to provide cells with additional transforming properties.
Conclusion:
This study discriminates oncogene-specific cell migration and invasion pathways mediated by Rho GTPases in colon cancer cells and reveals potential new oncogene-specific characteristics for targeted therapeutics.
Insights
This study reveals distinct cell migration and invasion pathways driven by BRAFV600E, KRASG12V, and HRASG12V oncogenes in colorectal cancer. Understanding these pathways offers new targets for cancer therapeutics.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Colorectal cancer involves genetic alterations, including oncogene activation.
- RAS and BRAF mutations are common but rarely found together.
- Rho GTPases (RhoA, Rac1, Cdc42) play critical roles in cancer cell invasion and metastasis.
Purpose of the Study:
- To differentiate the cell migration and invasion pathways utilized by BRAFV600E, KRASG12V, and HRASG12V oncogenes.
- To investigate the specific roles of RhoA, Rac1, and Cdc42 in oncogene-driven cancer progression.
Main Methods:
- Utilized colon adenocarcinoma cells with endogenous and ectopic oncogenic mutations (BRAFV600E, KRASG12V, HRASG12V).
- Employed kinase inhibitors and siRNAs to modulate signaling pathways and Rho GTPases.
- Correlated cell motility and invasion with cytoskeletal properties and Rho GTPase activities.
Main Results:
- BRAFV600E significantly enhanced cell migration and invasion via RhoA activation, mediated by the MEK-ERK pathway.
- KRASG12V promoted migration and invasion through filopodia and PI3K-dependent Cdc42 activation.
- HRASG12V induced increased cell migration, invasion, and Epithelial-Mesenchymal Transition (EMT) via Rac1.
- BRAF and KRAS oncogenes were found to cooperate with the TGFβ-1 pathway.
Conclusions:
- This study differentiates oncogene-specific cell migration and invasion pathways mediated by Rho GTPases in colon cancer.
- Identified potential new oncogene-specific therapeutic targets for colorectal cancer treatment.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a superfamily...
Cell Polarization by Rho Proteins
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

